Sbir: plant virus immunotherapy for solid tumors cancer immunotherapy has revolutionized oncology, yet challenges remain in achieving broad efficacy, durable responses, and manageable safety profiles
Active Grant Awarded
- Award ID
- R43CA314457
- Recipient
-
Plantiosx Inc. UEI SCY2F8XL9MD4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $406,500
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date 24% complete
- Place of performance
- San Diego, CA 92121, USA
Award details come from USAspending.gov.
About this award
The National Cancer Institute, within the Department of Health and Human Services' National Institutes of Health, awarded Plantiosx Inc. a grant obligating $406,500 on August 21, 2026, under Assistance Listing 93.395, Cancer Treatment Research. The award funds a Phase I SBIR project advancing cowpea mosaic virus (CPMV), a non-infectious plant virus, as an intratumoral immunotherapy toward clinical trials, through early translational work on chemistry, manufacturing, and controls (CMC) and IND-enabling toxicology studies.
Aim 1 establishes a qualified cowpea (Vigna unguiculata, black-eyed pea No. 5) seed bank for upstream CPMV production via molecular farming. Seeds will be certified, tested for viral infectivity and contamination, and stored as traceable sub-lots. Aim 2 transfers production technology from academic collaborators to establish a research CPMV bank at Plantiosx, where CPMV will be propagated and purified under validated protocols and thoroughly characterized to enable future clinical-manufacturing scale-up.
The ultimate completion date is August 31, 2027. Place of performance is San Diego, CA 92121. The awardee is identified by UEI SCY2F8XL9MD4. The source does not name sub-recipients.
Description
Intratumoral immunotherapy, where immune-stimulating agents are injected directly into tumors, represents a powerful strategy to reverse tumor-mediated immune suppression and initiate systemic anti-tumor immunity. Cowpea mosaic virus (CPMV), a non-infectious plant virus, has emerged as a promising intratumoral immunotherapy. Discovered and developed by our academic collaborators, CPMV has demonstrated potent efficacy in murine cancer models and most importantly in canine cancer clinical trials, overcoming immunosuppression in the tumor microenvironment and triggering systemic immune responses, memory, and suppression of metastases. CPMV intratumoral immunotherapy was curative in canine cancer patients with metastatic mammary tumors in the setting of neoadjuvant therapy. We have identified a clinical lead, PX101 (CPMV), and CO-founded plantiosx INC. To advance this platform toward clinical trials. This phase I sbir proposal focuses on early translational steps to enable chemistry, manufacturing, and controls (CMC) and IND-enabling toxicology studies. Aim 1 establishes a qualified cowpea (vigna unguiculata, black-eyed PEA no. 5) seed bank, required for upstream CPMV production via molecular farming. Seeds will be certified, tested for viral infectivity and contamination, and stored as traceable sub-lots. This seed bank will serve as a critical raw material resource. Aim 2 transfers production technology from academic collaborators to establish a research CPMV bank at plantiosx. CPMV will be propagated and purified under validated protocols and thoroughly characterized to enable future scale-up for clinical manufacturing. With deep expertise in virus-based immunotherapy and plant molecular farming, our team is well positioned to achieve these milestones within a 9-month period. Success will DE-risk future CMC and IND-enabling studies and advance PX101 as a novel, broadly applicable immunotherapy for solid tumors.
Quick answers
Who received award R43CA314457?
R43CA314457 was awarded to Plantiosx Inc. by National Cancer Institute (National Institutes of Health) on August 21, 2026.
How much is award R43CA314457 worth?
$406,500 has been obligated on R43CA314457.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award